InspireMD may sell 306,820 convertible preferred units in public sale

Bookrunner Dawson James will sell convertible preferreds with warrants

By Devika Patel

Knoxville, Tenn., June 14 – InspireMD, Inc. will sell 306,820 convertible preferred units in its public offering, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The company has registered up to $42,694,003 of stock for the deal, which was announced on April 14.

The units will each consist of one series B convertible preferred share and 100 five-year warrants.

Dawson James Securities, Inc. is the bookrunner.

Proceeds will be used for operations and general working capital requirements, to conduct sales activities, to develop new products and for general corporate purposes.

InspireMD is a medical device company based in Boston.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.